Detalhe da pesquisa
1.
Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination.
Clin Infect Dis
; 69(6): 1071-1078, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689799
2.
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.
Clin Infect Dis
; 73(4): e1011-e1017, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493317
3.
A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
Vaccine
; 42(6): 1230-1246, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326130
4.
A Practical Guide to Full Value of Vaccine Assessments.
Vaccines (Basel)
; 12(2)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400184
5.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Vaccine
; 42(7): 1445-1453, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036392
6.
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentations.
Vaccine
; 42(7): 1454-1460, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030421
7.
Vaccine value profile for Klebsiella pneumoniae.
Vaccine
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503661
8.
Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.
BMJ Glob Health
; 8(7)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414432
9.
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline.
Lancet Microbe
; 4(2): e113-e125, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528040
10.
Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries.
Commun Med (Lond)
; 3(1): 144, 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833540
11.
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification.
Front Public Health
; 11: 1165110, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377552
12.
The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance.
Hum Vaccin Immunother
; 18(6): 2145069, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420615
13.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Front Public Health
; 10: 809675, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35309224
14.
Case fatality risk of diarrhoeal pathogens: a systematic review and meta-analysis.
Int J Epidemiol
; 51(5): 1469-1480, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578827
15.
Estimating the future global dose demand for measles-rubella microarray patches.
Front Public Health
; 10: 1037157, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726626
16.
Association of enteropathogen detection with diarrhoea by age and high versus low child mortality settings: a systematic review and meta-analysis.
Lancet Glob Health
; 9(10): e1402-e1410, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534487
17.
Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis.
Front Immunol
; 12: 637114, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33815390
18.
Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection.
Vaccine
; 39(32): 4391-4398, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134905
19.
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.
Vaccine
; 39(31): 4266-4277, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33965254
20.
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens.
Vaccine
; 39(52): 7521-7525, 2021 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838322